Johnny Ray Gill dives into the complexity of Bobby Trey in ‘Cross’, explaining how trauma, truth, and lived experience shape one of the show’s most compelling characters.

Johnny Ray Gill doesn't rely on a traditional gym to stay in the elite shape that his fans have seen. Instead, the Cross star ...

Johnny Ray Gill exclusively opens up about his long-term career plans, who he hopes to work with in the future, and the major accolade he thinks he can win. Johnny Ray Gill prioritizes career ...

New Edition's March 21 concert at a packed Fiserv Forum in Milwaukee made a strong case for their induction into the Rock and Roll Hall of Fame. The three-hour show featured nonstop performances from ...

Chuck Berry and Vince Gill crossed paths briefly in the late 1970s, but Gill lost the evidence of that encounter within 24 ...

Colossal Star Trek Clue: Grammy-nominated singer Johnny Gill, who said, "This guy has been like a brother to me and we've riffed together for years. While singing is my day job, it is not his." 14K ...

Johnny Ray Gill isn’t just thinking about starring in one of Prime Video's most successful shows and his next roles. The Cross star exclusively explains to Men's Journal about the vision he has for ...

-Closed Private Placement Financing of up to $30 Million HUNTSVILLE, March 25, 2026 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina” or the "Company") (NYSE American: SER), a clinical-stage ...

FDA Grants IND Clearance for SER-252; Phase 1b Trial Initiated: In January 2026, Serina announced the U.S. Food and Drug Administration (FDA) had cleared the Investigational New Drug (IND) application ...

Ulta Beauty, Inc. (NASDAQ:ULTA) made our Mad Money recap, as Jim Cramer shared his take on the stock and highlighted resilient consumer spending despite the Iran conflict. Cramer highlighted the ...

– Acquisition of ALTO-207 targets Treatment-Resistant Depression (TRD) with a clinically-validated mechanism; Phase 2b trial on track to be initiated in the first half of 2026 – – External PAX-D study ...

SAN DIEGO, March 24, 2026 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a pharmaceutical company focused on the commercialization of VIZZ® (aceclidine ...